Infinx Acquires MedReceivables Advisor to Enhance Pathology Revenue Cycle Solutions

Written by Sirish Dixit

Infinx expands its pathology revenue cycle solutions by acquiring MedReceivables Advisor, enhancing billing, credentialing, and AI-powered revenue management.

Infinx Acquires MedReceivables Advisor to Enhance Pathology Revenue Cycle Solutions
Infinx acquires MedReceivables Advisor, boosting pathology billing, revenue cycle management, and AI-driven healthcare solutions.

Infinx, a leader in AI-powered patient access and revenue cycle management solutions, has acquired MedReceivables Advisor (MRA), a prominent provider of pathology billing and revenue cycle management services for hospital-based practices. This acquisition expands Infinx’s service offerings while reducing administrative burdens for healthcare providers.

By integrating MRA’s expertise, Infinx strengthens its solutions in pathology coding, billing, managed care contracting, credentialing, payer contract reviews, and fee schedule monitoring. Additionally, the partnership enhances services in eligibility verification, accounts receivable (A/R) and denials management, and litigation support, aligning with Infinx’s mission to optimize revenue capture for healthcare organizations.

Jaideep Tandon, CEO of Infinx, expressed enthusiasm for the acquisition, emphasizing how MRA’s capabilities complement Infinx’s vision of bridging providers, patients, and payers through technology. David Smith, CEO of MRA, highlighted the benefits for MRA clients, stating that the partnership enables access to expanded solutions, enhanced security with HITRUST certification, and AI-driven innovations.

With this strategic move, Infinx reinforces its commitment to delivering more advanced, connected, and secure revenue cycle solutions, helping healthcare providers improve efficiency and financial performance.

Share article